Sign in
  Edit search
111In-bevacizumab imaging of renal cell cancer and evaluatio…
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
Article, Chapter
Authors: I.M.E. Desar
Publication: Journal of Nuclear Medicine, Volume:51, Issue:11, Page(s):1707-1715
Published: 2010
ISSN: 0161-5505
  Full text availability for this item
View Full Text Source:Journal of Nuclear Medicine,Journal of Nuclear Medicine,The Society of Nuclear Medicine Opens in new Window
Journal:  Journal of Nuclear Medicine Source:The Society of Nuclear Medicine Opens in new Window
Collection:  The Society of Nuclear Medicine Opens in new Window
Coverage:
  • 1964~present; volume:5~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item